Jasper Therapeutics Inc

Research Jasper Therapeutics Inc (JSPR) on Bullrun: market cap USD 11.75M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerJSPR
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 11.75M
• Financial periodFY2025
• Net income-USD 75.80M

Valuation Snapshot

latest market cap is USD 11.75M.

Company Brief

Jasper Therapeutics reported Q4 FY2025 results, announced a search for strategic alternatives to maximize shareholder value, and faced conflicting analyst reactions ranging from price target cuts by Evercore ISI to bullish coverage notes. The company is currently exploring options beyond its current development…

The company remains loss-making as of the trailing twelve months period despite reporting a 29% year-over-year increase in net income, indicating improved profitability trends relative to prior periods without yet achieving positive earnings. No specific revenue figures or margin data were provided for this assessment.

Investors should monitor the outcome of Jasper's strategic alternatives search and any further updates on clinical progress for briquilimab given its central role in the company's value proposition.

Frequently asked questions

What is Jasper Therapeutics Inc's market cap?

Jasper Therapeutics Inc's market capitalization is USD 11.75M.

What does Jasper Therapeutics Inc do?

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.